Clinical Trial Update: Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating vascular and metabolic effects of fenofibrate/omega versus fenofibrate in hypertriglyceridemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• Fenofibrate/Omega (Fenofibrate and omega-3 fatty acids)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Hypertriglyceridemia | Phase 4 | Status: COMPLETED